Trial intelligence / Profile preview

Modified SOX Regimen in First-Line Gastric Adenocarcinoma

NCT01552980Phase 2Unknown

Sponsor
The Sixth Affiliated Hospital of Sun Yat-Sen University
Start
Mar 2012
Primary completion
Aug 2013
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of tegafur, oxaliplatin in gastric adenocarcinoma, sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Status: unknown.

02

Drugs

tegafuroxaliplatin
03

Conditions

gastric adenocarcinoma

Beyond the preview

Go deeper on NCT01552980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01552980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call